Gene variant could predict PTSD; Skyline, Clavis look into leukemia biomarkers;

> Variants of a gene that plays a role in regulating serotonin might serve as a predictor for post-traumatic stress disorder, according to data published in the Archives of General Psychiatry. Release

> Dutch biotech Skyline Diagnostics is getting together with Norway's Clavis Pharma to investigate gene expression biomarkers for acute myeloid leukemia. Item

> Adding two biomarkers to a scoring system, called GRACE, that predicts risk for acute coronary syndromes, did not improve the system's accuracy. Release

> FDA gives Fujirebio Diagnostics 510(k) clearance to market the company's test to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery. More here

> Molecular diagnostics company Vermillion has been awarded a new patent, number 8,014,952 , "Serum Biomarkers in Lung Cancer." Release

> Biomarkers can help predict which treatment ulcerative colitis patients will respond to. Item

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.